NanoString Technologies is rapidly becoming an important partner for scientists studying translational research and molecular diagnostics.
NanoString welcomes opportunities to partner with life science companies, diagnostic assay developers, commercial partners, and pharmaceutical companies with a need for an innovative diagnostic solution.
Contact us with your partnering ideas
From discovery to clinic: NanoString offers full capabilities
NanoString continues to improve and refine our technology capabilities with continuing research and development. We partner with companies and inventors with novel technologies to commercialize with our instruments and reagents. Contact us if you have a novel idea to partner with NanoString technology.
Translational Research and Diagnostic Development with NanoString
Examples of Research Oncology Signatures Developed with the nCounter® Analysis System:
- Subtypes of Diffuse Large B-Cell Lymphoma
- Prognosis in Hodgkin’s Lymphoma
- Subtypes of Medulloblastoma
- Transcriptional Signatures in Prostate Cancer
- miRNA for Endometriosis and Ovarian Cancer
Contact us if you have a multi-gene signature you would like to develop on the nCounter platform.